Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer
A SMART Platform for Scalable Biotherapeutic Development: cDNA to 200L Single-Use Stirred-Tank Bioreactor
Novel Synthetic Adsorptive Depth Filter Media for CHO Harvest Clarification
John Amara, Ph.D. and Michael Dullen Merck, 80 Ashby Road, Bedford, MA, 01730, USA
Volume Reduction and Process Optimization with Cadence Inline Concentrator
View All Featured ArticlesHeadline News
Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study
Lilly and Hims & Hers expand access to Zepbound and Foundayo
Moderna advances Bundibugyo ebolavirus vaccine toward Phase II/III study
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Characterisation of Host-Cell Proteins using Mass Spectrometry Enables Effective Purification Optimisation
Presented by Dr Li Zang of Biogen
31st October 2017
Antisense Oligonucleotide Purification Process: Successes and Challenges During Scale-up
Presented by Robert Gronke, Ph.D., Senior Principal Scientist, Technical Development, Biogen and Thomas Müller-Späth, Ph.D, CTO at YMC ChromaCon
10th March 2020
Patient-Centric Drug Delivery Strategies For Oral Paediatric Products
Presented by Dr. Carsten Timpe Senior Principal Scientist at Hoffman La Roche AG and Dr. Paolo Gatti Research Fellow and Formulation Manager for Aptalis Pharmaceutical Technologies
22nd April 2015
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Column Packing Protocol for Amsphere A3
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















